转移性前列腺癌中的细胞衰老:治疗机会或挑战 (评论)
Cen Jin1, Sijian Liao2, Guoliang Lu3
1Center for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, Guizhou 561113, P.R. China.
Molecular medicine reports
|July 12, 2024
概括
前列腺癌 (PCa) 治疗诱导的衰老具有双重挑战. 虽然最初阻碍了瘤的生长,但矛盾的是,它可以通过复杂的微环境促进PCa复发和转移.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 转移性前列腺癌 (PCa) 治疗仍然是一个重大的临床挑战.
- 像手术,放射治疗和雄激素受体向治疗等传统疗法诱导癌细胞衰老.
- 治疗耐药性是主要障碍,导致疾病进展和无法治愈的状态.
研究的目的:
- 审查PCa.中的治疗诱导衰老.
- 阐明衰老在PCa治疗结果中的双重作用.
- 探索衰老促进PCa转移的机制,并讨论治疗策略.
主要方法:
- 对前列腺癌治疗和衰老研究的文献综述.
- 在PCa.中分析与衰老相关的分泌表型 (SASP).
- 在衰老的瘤微环境中检查免疫细胞功能.
主要成果:
- 衰老的PCa细胞可以最初限制瘤生长并增强免疫清除.
- 衰老的微环境可以通过SASP和免疫抑制促进PCa复发和转移.
- 了解这些机制是开发新型治疗方法的关键.
结论:
- 衰老在前列腺癌的进展和治疗反应中起着复杂的双重作用.
- 针对与衰老相关的途径可能提供新的策略来克服治疗耐药性和预防转移.
- 对老化驱动的瘤微环境的进一步研究对于推进PCa治疗至关重要.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K


